Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

August 23, 2021

Study Completion Date

August 31, 2021

Conditions
Thyroid DiseasesSurgical InjuryNerve Monitoring
Interventions
DRUG

Neostigmine

"For the N group, neostigmine (0.03 mcg / kg) and glycopyrrolate with a 5:1 ratio will be administered just after tracheal intubation.~Investigators evaluate the quality of signal of IONM during the surgery."

DRUG

Normal saline

"For the NS group, neostigmine normal saline (0.09 cc/kg; the same volume of the group N) will be administered just after tracheal intubation.~Investigators evaluate the quality of signal of IONM during the surgery."

Trial Locations (1)

07061

Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

All Listed Sponsors
collaborator

SMG-SNU Boramae Medical Center

OTHER

lead

Seoul National University Hospital

OTHER